Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus

Table 2

The profile of autoantibodies in 2104 SLE patients from CSTAR cohort study.

	Patients number	Positivity (%)
Anti-nuclear antibody (ANA)	2063	98.1
Anti-double stranded DNA (anti-dsDNA) antibody	699	33.2
Anti-Sm antibody	350	16.6
Anti-SSA antibody	497	23.6
Anti-SSB antibody	224	10.7
Anti-u1 small-nuclear RNA-protein (anti-RNP) antibody	189	8.9
Anti-ribosomal RNA-protein (anti-rRNP) antibody	255	12.7
Anti-phospholipid (APL) antibody	414/937^$	44.1
Anti-SSA and anti-SSB antibody positive simultaneously	199	9.5
Anti-Sm and anti-RNP antibody positive simultaneously	142	6.7

$Actually detected number of patients.